Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BN.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.2.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.96EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EW.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BW.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FB.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GP.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBVEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCYEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BU.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCVEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.31.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.78EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HR.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HS.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HU.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used